57 related articles for article (PubMed ID: 655224)
1. Possible adverse effects from topical ocular 10% phenylephrine.
Fraunfelder FT; Scafidi AF
Am J Ophthalmol; 1978 Apr; 85(4):447-53. PubMed ID: 655224
[No Abstract] [Full Text] [Related]
2. Intracameral phenylephrine for surgical mydriasis and intraoperative floppy-iris syndrome: systemic adverse effects and optimal dose.
Chua MJ; Varshney N; Eke T
J Cataract Refract Surg; 2024 Feb; 50(2):187-194. PubMed ID: 37748029
[TBL] [Abstract][Full Text] [Related]
3. Safety of tropicamide and phenylephrine in pupillary mydriasis for cataract surgery.
K Lodhi SA; Ramsali MV; Kulkarni DK; Surender P; Murty S
Saudi J Ophthalmol; 2021; 35(2):108-111. PubMed ID: 35391812
[TBL] [Abstract][Full Text] [Related]
4. Effect of Topical Phenylephrine 2.5% on Episcleral Venous Pressure in Normal Human Eyes.
Kazemi A; McLaren JW; Sit AJ
Invest Ophthalmol Vis Sci; 2021 Oct; 62(13):4. PubMed ID: 34617960
[TBL] [Abstract][Full Text] [Related]
5. Adverse Cardiovascular Effects of Phenylephrine Eye Drops Combined With Intravenous Atropine.
Li Q; Pang J; Deng Y; Zhang S; Wang Y; Gao Y; Yuan X; Wei Y; Zhang H; Tan J; Chi W; Guo W
Front Pharmacol; 2020; 11():596539. PubMed ID: 33584276
[No Abstract] [Full Text] [Related]
6. Safety and efficacy of a standardized intracameral combination of mydriatics and anesthetic for cataract surgery in type-2 diabetic patients.
Labetoulle M; Behndig A; Tassignon MJ; Nuijts R; Mencucci R; Güell JL; Pleyer U; Szaflik J; Rosen P; Bérard A; Chiambaretta F; Cochener-Lamard B;
BMC Ophthalmol; 2020 Mar; 20(1):81. PubMed ID: 32126990
[TBL] [Abstract][Full Text] [Related]
7. Systemic exposure to intracameral vs topical mydriatic agents: in cataract surgery.
Guell J; Behndig A; Pleyer U; Jaulerry S; Rozot P; Pisella PJ; Robert PY; Lanzl I; Pourjavan S; Aguiar C; Fernandez J; Grabner G; Mencucci R; Chiambaretta F; Labetoulle M
Clin Ophthalmol; 2019; 13():811-819. PubMed ID: 31118559
[TBL] [Abstract][Full Text] [Related]
8. Response to phenylephrine testing in upper eyelids with ptosis.
Grace Lee N; Lin LW; Mehta S; Freitag SK
Digit J Ophthalmol; 2015; 21(3):1-12. PubMed ID: 27330465
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy and safety of a standardised intracameral combination of mydriatics and anaesthetics for cataract surgery.
Labetoulle M; Findl O; Malecaze F; Alió J; Cochener B; Lobo C; Lazreg S; Hartani D; Colin J; Tassignon MJ; Behndig A;
Br J Ophthalmol; 2016 Jul; 100(7):976-985. PubMed ID: 26531052
[TBL] [Abstract][Full Text] [Related]
10. Long Term and Intensive Use of Ophthalmic Topical Corticosteroids and the Risk of Positive Doping Test in Athletes: A Case Report.
Seif Barghi T; Kobarfard F; Hashemian A; Zebardast J
Asian J Sports Med; 2015 Sep; 6(3):e24621. PubMed ID: 26448853
[TBL] [Abstract][Full Text] [Related]
11. The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery.
Lawuyi LE; Gurbaxani A
Clin Ophthalmol; 2015; 9():1249-54. PubMed ID: 26203214
[TBL] [Abstract][Full Text] [Related]
12. Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions.
Grob SR; Gonzalez-Gonzalez LA; Daly MK
Clin Ophthalmol; 2014; 8():1281-9. PubMed ID: 25061276
[TBL] [Abstract][Full Text] [Related]
13. Effect of 10% phenylephrine eye drops on systemic blood pressure in normotensive & hypertensive patient.
Bhatia J; Varghese M; Bhatia A
Oman Med J; 2009 Jan; 24(1):30-2. PubMed ID: 22303506
[TBL] [Abstract][Full Text] [Related]
14. Can children undergoing ophthalmologic examinations under anesthesia be safely anesthetized without using an IV line?
Vigoda MM; Latiff A; Murray TG; Tutiven JL; Berrocal AM; Gayer S
Clin Ophthalmol; 2011; 5():503-8. PubMed ID: 21573039
[TBL] [Abstract][Full Text] [Related]
15. The comparison of mydriatic effect between two drugs of different mechanism.
Park JH; Lee YC; Lee SY
Korean J Ophthalmol; 2009 Mar; 23(1):40-2. PubMed ID: 19337478
[TBL] [Abstract][Full Text] [Related]
16. Pupil dilation with intracameral lidocaine during phacoemulsification: Benefits for the patient and surgeon.
Nikeghbali A; Falavarjani KG; Kheirkhah A
Indian J Ophthalmol; 2008; 56(1):63-4. PubMed ID: 18158406
[TBL] [Abstract][Full Text] [Related]
17. Phenylephrine 2.5% and 10% in phacoemulsification under topical anaesthesia: is there an effect on systemic blood pressure?
Kenawy NB; Jabir M
Br J Ophthalmol; 2003 Apr; 87(4):505-6. PubMed ID: 12642324
[No Abstract] [Full Text] [Related]
18. Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence.
Cheetham MJ; Kamm MA; Phillips RK
Gut; 2001 Mar; 48(3):356-9. PubMed ID: 11171825
[TBL] [Abstract][Full Text] [Related]
19. Organization and transmitter specificity of medullary neurons activated by sustained hypertension: implications for understanding baroreceptor reflex circuitry.
Chan RK; Sawchenko PE
J Neurosci; 1998 Jan; 18(1):371-87. PubMed ID: 9412514
[TBL] [Abstract][Full Text] [Related]
20. Systemic and local tolerability of ophthalmic drug formulations. An update.
Hugues FC; Le Jeunne C
Drug Saf; 1993 May; 8(5):365-80. PubMed ID: 8099291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
